Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2012) 29 P1535

Pamukkale University, Denizli, Turkey.


Adiponectin, is an adipocyte derived hormone possess insulin-sensitizing, antiatherogenic, and antiinflammatory properties. The aim of this study to evaluate adiponectin levels at acromegalic patients according to healthy subjects in relation with ecocardiographic findings. We included 30 subjects (15 male, 15 female) were diagnosed as acromegaly and 30 healthy (10 male, 20 female) subjects. Mean ages of both group were similar. Serum glucose, insulin, GH, IGF1 (insulin like growth factor 1), adiponectin levels were obtained and insulin resistance were calculated by HOMA-IR. Echocardiography of subjects were performed. Adiponectin levels were significantly higher at acromegalic group than control group. At acromegalic group, there was no statistically meaningful relation between serum adiponectin and GH, IGF1 levels. IVST (thickness of interventricular septum in diastole), PWT (thickness of left ventricular posterior wall in diastole), LVMI (left ventricular mass index), E/A ratio, DT (deceleration time of E-wave), ET(ejection time), IVRT (Isovolumetric relaxation time), VPR (velocity of mitral flow propagation), LVESV (left ventricle end systolic volume) values were increased results were statistically meaningful. At acromegaly group adiponectin levels were positively related with LVMI. Adiponectin levels may be indicator of the cardiac involvement acromegaly.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This work was supported, however funding details unavailable.

Clinical and echocardiographic findings of groups.
Acromegaly (n=30)Control (n=30)P value
BMI (kg/m2)29.06±6.0825.06±2.780.001*
FPG (mg/dl)113.53±28.8789.20±6.260.001*
Insulin (μIU/ml)8.38±9.436.51±2.45NS
GH (ng/l)15.39±14.130.68±1.290.001*
IGF1 (ng/l)649.53±373.45124.54±44.860.001*
Adiponec tin (μg/ml)84.13±101.1828.84±58.720.001*
IVST (mm)10.46±1.386.93±2.930.000*
PWT (mm)10.36±1.676.93±3.030.000*
LVMI (g/m2)122.98±30.1876.65±15.080.000*
E/A ratio0.98±0.311.19±0.360.044*
DT219.83±50.99191.06±32.90.012*
ET314.03±40.04276.93±26.720.000*
IVRT106.20±15.3497.00±11.730.012*
VPR59.83±14.2445.06±8.870.000*
LVESV39.13±11.2431.90±11.060.001*
EF (%)63.00±6.5564.06±5.63NS
*P value<0.05; statistically significant. NS: Non significant. EF: Ejection fraction.

Volume 29

15th International & 14th European Congress of Endocrinology

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts